Statistics
Publications
8
Citations
409
H-Index
8
Active since
1988
Satoru Ito is an author at Taiho Pharmaceutical (Japan) specializing in targeted cancer therapy, tyrosine kinase inhibitors, and molecular oncology.
Publications per year
1988–2024
8
8
Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use
Satoru Ito, Sachie Otsuki, Hirokazu Ohsawa et al. · ACS Medicinal Chemistry Letters · 2023 · 34 citations · Full text
Medicine, Oncology, Pharmacology +15
1–5 of 8